Evidence map›Paper›PMID 38991852›Full record

ArticleGigaScience2024

Omada: robust clustering of transcriptomes through multiple testing.

Sokratis Kariotis, Pei Fang Tan, Haiping Lu, Christopher J Rhodes, Martin R Wilkins, Allan Lawrie, Dennis Wang

Abstract read
In one paragraph

Article in GigaScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sokratis KariotisSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), 30 Medical Dr, 117609, Singapore, Republic of Singapore.ORCID 0000-0001-9993-6017
Pei Fang TanSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), 30 Medical Dr, 117609, Singapore, Republic of Singapore.ORCID 0000-0003-1475-8886
Haiping LuDepartment of Computer Science, University of Sheffield, Regent Court, 211 Portobello, S1 4DP, Sheffield, United Kingdom.ORCID 0000-0002-0349-2181
Christopher J RhodesNational Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse St, SW3 6LY, London, United Kingdom.ORCID 0000-0002-4962-3204
Martin R WilkinsNational Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse St, SW3 6LY, London, United Kingdom.ORCID 0000-0003-3926-1171
Allan LawrieNational Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse St, SW3 6LY, London, United Kingdom.ORCID 0000-0003-4192-9505
Dennis WangSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), 30 Medical Dr, 117609, Singapore, Republic of Singapore.ORCID 0000-0003-0068-1005

Funding

Academy of Medical Sciences APR7_1002British Heart Foundation PG/11/116/29288British Heart Foundation SP/12/12/29836British Heart Foundation SP/18/10/33975
6 · The paper itself

Abstract

backgroundCohort studies increasingly collect biosamples for molecular profiling and are observing molecular heterogeneity. High-throughput RNA sequencing is providing large datasets capable of reflecting disease mechanisms. Clustering approaches have produced a number of tools to help dissect complex heterogeneous datasets, but selecting the appropriate method and parameters to perform exploratory clustering analysis of transcriptomic data requires deep understanding of machine learning and extensive computational experimentation. Tools that assist with such decisions without prior field knowledge are nonexistent. To address this, we have developed Omada, a suite of tools aiming to automate these processes and make robust unsupervised clustering of transcriptomic data more accessible through automated machine learning-based functions.

findingsThe efficiency of each tool was tested with 7 datasets characterized by different expression signal strengths to capture a wide spectrum of RNA expression datasets. Our toolkit's decisions reflected the real number of stable partitions in datasets where the subgroups are discernible. Within datasets with less clear biological distinctions, our tools either formed stable subgroups with different expression profiles and robust clinical associations or revealed signs of problematic data such as biased measurements.

conclusionsIn conclusion, Omada successfully automates the robust unsupervised clustering of transcriptomic data, making advanced analysis accessible and reliable even for those without extensive machine learning expertise. Implementation of Omada is available at http://bioconductor.org/packages/omada/.

Indexed as

Gene Expression ProfilingSoftwareTranscriptomeAlgorithmsCluster AnalysisComputational BiologyHigh-Throughput Nucleotide SequencingHumansMachine LearningSequence Analysis, RNAcluster analysisgene expressionsoftware toolkitunsupervised learning

Identifiers

PMID38991852
PMCPMC11238428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.